期刊
IMMUNOLOGY LETTERS
卷 112, 期 1, 页码 58-60出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.imlet.2007.07.001
关键词
-
类别
Attempts to produce a vaccine to human cytornegalovirus (HCMV) have failed. The principal target of the humoral immune response to HCMV is the viral envelope glycoprotein gB, which contains several immunodominant epitopes. Here we discuss human antibodies reacting with gB and offer an explanation as to why most humans make antibodies to an epitope that does not always elicit neutralizing antibodies. We suggest modifications to gB for an improved HCMV vaccine design. (C) 2007 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据